% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INPROCEEDINGS{Froning:173061,
author = {Froning, Martina and Hill, Peter},
title = {{I}nternal {D}osimetry after {I}nhalation of {UF}6 - {A}
{C}ase {S}tudy},
reportid = {FZJ-2014-06474},
year = {2014},
abstract = {INTERNAL DOSIMETRY AFTER INHALATION OF UF6 - A CASE STUDYM.
Froning, P. HillForschungszentrum Jülich GmbH, S-BI, 52425
Jülich, GermanyIntroduction: During a release of UF6 in a
nuclear installation in Germany an employee was contaminated
externally and internally. Inhaled uranium is in the
chemical form UF6 very well soluble (class F) and can be
easily taken up into blood and the lymphatic
system.Monitoring: Extensive incorporation monitoring of
urine and feces, as well as measurements of blood,
nose-blow- and sputum samples on 234U, 235U and 238U
followed immediately after the incident. The total
monitoring period covered about 4 weeks.To enhance the
excretion rate a solution of 8.4 percent sodium bicarbonate
was administrated in the first few days as a means of
medical precaution. During this time urine and feces samples
taken were essentially of low volume (e.g. spot samples).
Excretion rates have been analyzed by means of ICP-MS and
α-spectrometry. The latter was used for quality assurance
of the results. The laboratory is flexibly accredited (DIN
ISO/IEC 17025:2005) for these test methods.Dose assessment:
Internal dose has been assessed following the rules of the
official German guideline on incorporation monitoring. This
guideline must be used for legal purposes. An effective Dose
of E = 0.8 mSv and a lung dose of HLung = 14.5 mSv have been
calculated. Additionally expert software has been used for
internal dose calculation. Since excretion rates in the
beginning of the monitoring period were enhanced, later
samples were especially helpful in realistically determing
internal dose.Final remarks: The biocinetic uranium model of
ICRP78[1] seems not to be adequate to describe excretion
within the first hours after intake. The data obtained from
spot samples during the first day indicate an
underestimation of exretion rates by several orders of
magnitude. The study shows that extended follow-up
monitoring can help to clarify the dose relevant medium-term
systemic uptake after an incident.A recent communication of
the case study in English (extended abstract) can be found
in ref. [2].[1] ICRP Publication 78; Individual Monitoring
for Internal Exposure of Workers; Annals of the ICRP Vol. 27
No. 3/4, 1997[2] M.Froning, H.Doerffel and P.Hill; Internal
Dosimetry after Inhalation of UF6 - A Case Study; Fourth
European IRPA Congress ‘Radiation Protection Culture – A
global challenge, June 23-27,2014, Geneva, Switzerland; Book
of abstracts, Paper PS5-04/6;
http://www.irpa2014europe.com/downloads (last accessed:
July, 28th 2014)},
month = {Sep},
date = {2014-09-24},
organization = {VI International Conference
'Semipalatinsk Test Site: Radiation
Legacy and Development Perspectives',
Kurchatow (Kazakhstan), 24 Sep 2014 -
26 Sep 2014},
subtyp = {After Call},
cin = {S-BI / S-B},
cid = {I:(DE-Juel1)S-BI-20100518 / I:(DE-Juel1)S-B-20090406},
pnm = {899 - ohne Topic (POF2-899)},
pid = {G:(DE-HGF)POF2-899},
typ = {PUB:(DE-HGF)24},
url = {https://juser.fz-juelich.de/record/173061},
}